Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05630014
Other study ID # 22-01093
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 3, 2024
Est. completion date October 31, 2024

Study information

Verified date April 2024
Source NYU Langone Health
Contact Shih-Yin Lin
Phone (720) 883-5715
Email SL199@nyu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers may aid prevention, early detection, and management of DSD. The purpose of the proposed study is two-fold. First, the investigators will develop a family-centered, mHealth-enhanced DSD caregiving mastery program ("Aliviado DSD Caregiving Mastery Program") through a 5-week co-design workshop with 8 family caregivers (Aim 1). The investigators will adapt/refine the existing clinician-centered DSD contents and an mHealth app from the evidence-based "Aliviado Dementia Care" program for use by family caregivers to support their day-to-day implementation of DSD detection, prevention, and management tasks in the community. Second, the investigators will pilot test the full Aliviado DSD Caregiving Mastery Program with 30 family caregivers of PLWD at high risk for delirium, assessing feasibility, acceptability, app usability, and preliminary program impact (Aim 2).


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date October 31, 2024
Est. primary completion date October 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: To be eligible as a "dementia caregiver" in the co-design workshop, an individual must: - be at least 18 years old, - be English-speaking, - provide at least 8 hours of unpaid care weekly or live with a community-dwelling PLWD, - self-identify as unfamiliar with DSD, - have the capacity to consent, and - have Internet access To be eligible as a "DSD caregiver" in the co-design workshop, an individual must: - be at least 18 years old, - be English-speaking, - be a current or past dementia caregiver with experience caring for a relative or friend during his/her DSD episode within the past 12 months, - have the capacity to consent, and - have Internet access. To be eligible to participate in the feasibility trial, an individual must meet all of the following criteria: - Being 18 years old or older, - English-speaking, - Providing at least 8 hours of unpaid care per week to, or living with, a community dwelling PLWD whose Delirium Risk Assessment Score >=5, - Having the capacity to give informed consent, and - Having a smartphone with Internet access. Exclusion Criteria: - Individuals who are blind or deaf will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Aliviado DSD Caregiving Mastery Program
Family caregiver intervention consisting of mHealth-app based educational videos and articles; caregiver-administered assessment tools and care plans; and motivational push notification reminders and encouragements.

Locations

Country Name City State
United States NYU Langone Health New York New York
United States University of Pittsburgh Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
NYU Langone Health National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants who Complete the Study Measure of feasibility. Feasibility indicated by retention rate of 85%. Week 6
Primary Program Satisfaction Questionnaire Score Questionnaire comprises 13 Likert-type questions to assess program satisfaction and willingness to recommend the program. Includes one optional open-ended question to provide additional feedback. Week 6
Primary Number of Participants who Complete all Training Videos by Week 2 Measure of acceptability. Up to Week 2
Primary Number of Participants who Complete Weekly Delirium Screening at Least Twice by Week 6 Measure of acceptability. Up to Week 6
Primary Modified IBM Computer Usability Satisfaction Questionnaire Score Developed by the Aliviado team; consists of 24 Likert-type questions, plus 3 optional open-ended questions to provide additional feedback. Higher scores indicate greater usability. Week 6
Secondary Change from Baseline in Caregiver Delirium Knowledge Questionnaire Score at Week 2 19-item assessment of caregivers' delirium knowledge. Item response options include "yes," "no," and "I don't know." Correct responses receive a score of 1, incorrect responses receive a score of 0. The total score ranges from 0-19; higher scores indicate greater delirium knowledge. Baseline, Week 2
Secondary Change from Baseline in Caregiver Delirium Knowledge Questionnaire Score at Week 6 19-item assessment of caregivers' delirium knowledge. Item response options include "yes," "no," and "I don't know." Correct responses receive a score of 1, incorrect responses receive a score of 0. The total score ranges from 0-19; higher scores indicate greater delirium knowledge. Baseline, Week 6
Secondary Change from Baseline in Modified Caregiver Strain Index Score at Week 6 13-item assessment of strain related to care provision. Items are scored on a Likert scale from 0 (no) to 2 (Yes, on a regular basis). The total score is the sum of responses and ranges from 0 to 26; higher scores indicate greater strain. Baseline, Week 6
Secondary Change from Baseline in Center for Epidemiological Studies Depression Scale (CES-D) Score at Week 6 20-item assessment of symptoms of depression over the past 7 days. The total score ranges from 0 to 60, with higher scores indicating the presence of more symptomatology. Baseline, Week 6
Secondary Change from Baseline in Short Form Zarit Burden Interview Score at Week 6 12-item assessment of caregiver burden. Items are scored on a Likert scale from 0 (never) to 4 (nearly always). The total score is the sum of responses and ranges from 0 to 48. A score of 0-10 indicates no to mild burden; 10-20 indicates mild to moderate burden; and greater than 20 indicates high burden. Baseline, Week 6
Secondary Change from Baseline in DSD Caregiving Mastery Assessment Score at Week 2 14-item DSD Competence Scale modified from Pearline's Competence Scale with additional items developed by the Aliviado team to assess confidence and completion of DSD prevention, detection, and management tasks. Higher scores indicate greater levels of mastery. Baseline, Week 2
Secondary Change from Baseline in DSD Caregiving Mastery Assessment Score at Week 6 14-item DSD Competence Scale modified from Pearline's Competence Scale with additional items developed by the Aliviado team to assess confidence and completion of DSD prevention, detection, and management tasks. Higher scores indicate greater levels of mastery. Baseline, Week 6
See also
  Status Clinical Trial Phase
Recruiting NCT05391334 - Early Fall Risk Detection and Fall Prevention Among Inpatients With Delirium
Terminated NCT03941119 - Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to Hospital N/A
Completed NCT05398211 - Music Therapy as a Treatment for Delirium in Acutely Hospitalized Older Patients N/A
Active, not recruiting NCT06176625 - Sight and Hearing Investigation Into Effects on Delirium N/A
Recruiting NCT04973709 - Prevalence of Dementia and Delirium in Outpatient Clinics (DESTAN Trial)
Recruiting NCT05915377 - Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Completed NCT01505257 - Early Nurse Detection and Management of Delirium N/A
Completed NCT01394328 - Delirium in Persons With Dementia N/A